Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2018

May 31, 2018

35146_dirs_2018-05-31_b3dec8f7-72ac-4ccb-a5e2-4ea9e5685f95.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-05-29

Reporting Person: Accelmed Growth Partners, L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (GP), L.P. (10% Owner)
Reporting Person: Accelmed Growth Partners (AGP) Ltd (10% Owner)
Reporting Person: Accelmed Growth Partners Management Ltd. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $0.001 par value per share 12037037 Direct
Common Stock, $0.001 par value per share 12037037 Indirect
Common Stock, $0.001 par value per share 12037037 Indirect
Common Stock, $0.001 par value per share 12037037 Indirect

Footnotes

F1: These shares are held directly by Accelmed Growth Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Growth Partners (GP), L.P., the general partner of Accelmed Growth Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Growth Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Growth Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of its pecuniary interest in the shares.